Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC
{{output}}
The effectiveness of direct acting antiviral (DAA) therapy in patients with active hepatocellular carcinoma (HCC) is poorly defined. NHS England approved DAA therapy for all viraemic patients, including those with HCC. The aim of this retrospective study is to... ...
